Patient Advocacy

Putting Patients at the Center of Innovation

Putting Patients at the Center of Innovation

Putting Patients at the Center of Innovation

Elevating patient, caregiver, and clinician voices through education, awareness, and meaningful collaboration.

Elevating patient, caregiver, and clinician voices through education, awareness, and meaningful collaboration.

Elevating patient, caregiver, and clinician voices through education, awareness, and meaningful collaboration.

Clinician supporting a patient with education materials

Education • Awareness • Collaboration

Our Commitment

Our Commitment

We believe meaningful innovation begins with listening. Through collaboration with clinicians, researchers, patient advocates, and caregivers, we strive to raise awareness of diseases with significant unmet need and help ensure that the patient experience remains at the center of scientific progress.

Educate

Raise awareness

Amplify voices

Support patients & caregivers

Why This Matters

For many patients living with serious diseases, the challenges extend far beyond the diagnosis. Symptoms can affect physical comfort, emotional well-being, daily activities, relationships, and quality of life. Through education and collaboration with experts, our goal is to help increase understanding of these experiences and the importance of addressing unmet medical needs.

For many patients living with serious diseases, the challenges extend far beyond the diagnosis. Symptoms can affect physical comfort, emotional well-being, daily activities, relationships, and quality of life. Through education and collaboration with experts, our goal is to help increase understanding of these experiences and the importance of addressing unmet medical needs.

Featured Focus: Malignant Fungating Wounds

Malignant fungating wounds (MFWs), also called fungating tumors or ulcerating cancer wounds, occur when cancer grows into and breaks through the skin. These complex wounds may cause physical symptoms like odor, pain, bleeding, drainage, and significant emotional and social distress. Learn more below.

Malignant fungating wounds (MFWs), also called fungating tumors or ulcerating cancer wounds, can turn everyday life into a struggle with physical symptoms like malodor, pain, and bleeding, as well as social isolation and emotional distress. These complex wounds.occur when cancer grows into and breaks through the skin. Patients and caregivers deserve greater understanding and better support. Learn more below.

Malignant fungating wounds (MFWs), also called fungating tumors or ulcerating cancer wounds, occur when cancer grows into and breaks through the skin. These complex wounds may cause physical symptoms like odor, pain, bleeding, drainage, and significant emotional and social distress. Learn more below.

Educational Resources

Educational Resources

Malignant Fungating Wounds

Malignant fungating wounds can create significant physical, emotional, and social challenges for people living with cancer and those who care for them. By supporting education, increasing awareness, and listening to patients, caregivers, and healthcare professionals, we hope to improve understanding of this often underrecognized condition.

Expert Perspectives

Expert Perspectives

Hear directly from clinicians and experts discussing the realities of living with diseases that remain underrecognized, the challenges patients and caregivers face, and why continued education matters.

Hear directly from clinicians and experts discussing the realities of living with diseases that remain underrecognized, the challenges patients and caregivers face, and why continued education matters.

Understanding Malignant Fungating Wounds | Dr. Charles Tilley

Dr. Charles Tilley, PhD

Disease awareness

The Patient Burden and Unmet Need of Malignant Fungating Wounds | Susy Pramod

Susy Pramod

Patient burden

Collaborating With Our Community

We welcome opportunities to collaborate with clinicians, researchers, advocacy organizations, and healthcare professionals to support disease education, awareness, and engagement with patients and caregivers.

We welcome opportunities to collaborate with clinicians, researchers, advocacy organizations, and healthcare professionals to support disease education, awareness, and engagement with patients and caregivers.

A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.